Clinical Trial Update: Vorinostat in Children [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating vorinostat in pediatric patients with relapsed solid tumors, lymphoma, or leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Solid Tumors

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: National Center for Tumor Diseases, Heidelberg | Conditions: Children With Relapsed Solid Tumor, Lymphoma or Leukemia | Phase 1, Phase 2 | Status: COMPLETED